Bill Paxton MD PhD Fcap
About Bill Paxton MD PhD Fcap
Bill Paxton MD PhD Fcap serves as the Senior Medical Director at Mirati Therapeutics, bringing extensive experience in clinical laboratory direction and drug development across various medical fields, including oncology and infectious diseases.
Current Role at Mirati Therapeutics
Bill Paxton serves as the Senior Medical Director at Mirati Therapeutics, a position he has held since 2020. In this role, he utilizes his extensive background in clinical development and laboratory medicine to guide the company's medical strategies and initiatives. His responsibilities include overseeing clinical trials and ensuring compliance with regulatory standards. His expertise in drug development spans from pre-clinical phases to phase III studies, contributing to the advancement of innovative therapies.
Previous Experience at Spectrum Pharmaceuticals
Prior to his current role, Bill Paxton worked as the Executive Medical Director of Clinical Development at Spectrum Pharmaceuticals, Inc. from 2019 to 2020. During his nine-month tenure in Irvine, California, he focused on clinical strategy and development, leveraging his knowledge in oncology and drug development to support the company's objectives.
Education and Professional Training
Bill Paxton's educational background includes a Bachelor of Arts in Biological Sciences from the University of Chicago and a Doctor of Philosophy in Microbiology and Immunology from the University of Illinois at Chicago. He also earned his Doctor of Medicine degree from the University of Minnesota Medical School. Additionally, he completed a residency in Laboratory Medicine and Anatomic Pathology at the University of Washington School of Medicine and a fellowship in Clinical Transfusion Medicine at Puget Sound Blood Center.
Expertise in Clinical Laboratories
Bill Paxton possesses extensive experience in directing clinical laboratories specializing in genetic, oncology, immune, and infectious disease-based conditions. He has successfully overseen laboratories through various licensing inspections, including CLIA, CAP, and New York state. His expertise includes validation and interpretation of molecular pathology lab-developed tests and next-generation sequencing (NGS) DNA tests, making him a subject matter expert in these areas.
Consulting Roles and Contributions
From 2006 to 2015, Bill Paxton served as a Consulting Physician and Central BILAG Reader at ReSearch Pharmaceutical Services and PRA International. His consulting roles allowed him to contribute to clinical research and development projects, enhancing his understanding of clinical trials and patient care. He also held the position of Medical Director and Clinical Laboratory Director at Epic Sciences from 2016 to 2017, further solidifying his leadership in the clinical laboratory field.